from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2231c/cobC

LFCtreatmentdescriptionclass of inhibitor

-0.630

Amikacinug/mL Amikacintranslation

-0.940

Cap5-10ug/mL Capreomycintranslation

-1.306

Rox10-50 ug/mL Roxithromycintranslation

0.002

SM2-5 ug/mL Streptomycintranslation

0.554

Tet5-10 ug/mL Tetracyclinetranslation

0.675

Rif0.2-5ug/mL Rifampicintranscription

0.663

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.119

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.145

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.744

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.217

Clofazimine10-13 ug/mL Clofaziminerespiration

0.536

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.104

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.742

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.109

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.337

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.635

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.935

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.583

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.877

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.063

KCN5-20 ug/mL Potassium cyaniderespiration

1.119

NaN30.2-2 mM Sodium aziderespiration

0.529

Nigericin50 uM Nigericinrespiration

-0.311

TRC10-150 ug/mL Triclosanrespiration

-1.109

TRZ10-25 ug/mL Thioridazinerespiration

-2.166

Valinomycin0.5-10 uM Valinomycinrespiration

1.888

ZnSO42 mM ZnSO4respiration

-0.750

menadione6-10 ug/mL Menadionerespiration

-0.527

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.158

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.303

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.469

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.008

NRP_1Non-replicating persistence stage 1dosRassociated

0.716

Amp0.2mg/mL AmpicillincellWall

-0.135

Cephalexin20-100 ug/mL CephalexincellWall

0.472

Cerulenin0.32-5 ug/mL CerulenincellWall

0.278

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.099

EMB10-20 ug/mL EthambutolcellWall

0.810

Eta12-40 ug/mL EthionamidecellWall

0.236

INH0.2-0.4 ug/mL IsoniazidcellWall

0.347

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.463

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.851

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.255

BZA0.12 mg/mL BenzamidearomaticAmides

0.262

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.107

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.568

H2O24 mM hydrogen peroxideDNAdamaging

0.275

Levo10 ug/mL LevofloxacinDNAdamaging

-0.010

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.211

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.383

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.047

UVUV-irradiationDNAdamaging

-0.994

ARP41-4 ug/mL Antitubercular compound ARP4?

0.175

Antimycin12.5-50 ug/mL Antimycin A?

0.916

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.760

PA_110-50 ug/mL Antitubercular compound PA-1?

0.488

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.891

PA8240.2-2 ug/mL PA-824?

-0.193

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.242

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.691

Verapamil50 uM Verapamil?

1.033

mercaptoethanol2 mM 2-Mercaptoethanol?

0.847

methoxatin10-20 ug/mL Methoxatin?